#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1032228	B	Inhibition of CDC2L2 at 3 uM		1	ALA1142492	single protein format	Scientific Literature
2.	ALA1063794	B	Binding constant for CDC2L2 kinase domain	Homo sapiens	38	ALA1150977	single protein format	Scientific Literature
3.	ALA1052882	B	Inhibition of CDC2L2 assessed as enzyme activity at 1 uM relative to untreated control		1	ALA1155237	single protein format	Scientific Literature
4.	ALA1168818	B	Inhibition of CDC2L2 at 1 uM		6	ALA1165965	single protein format	Scientific Literature
5.	ALA1174101	B	Inhibition of CDC2L2 at 10 uM		2	ALA1177794	single protein format	Scientific Literature
6.	ALA1244756	B	Binding affinity to CDC2L2		7	ALA1240346	single protein format	Scientific Literature
7.	ALA1827265	B	Activity of CDC2L2 kinase at 1 uM		1	ALA1821651	single protein format	Scientific Literature
8.	ALA1908830	B	Binding constant for CDC2L2 kinase domain		72	ALA1908390	single protein format	Scientific Literature
9.	ALA2209341	B	Inhibition of CDC2L2 assessed as residual activity at 10 uM relative to control		1	ALA2203081	single protein format	Scientific Literature
10.	ALA2428177	B	Competitive binding affinity to CDC2L2 (unknown origin) at 10 uM in presence of ATP relative to control	Homo sapiens	4	ALA2424622	single protein format	Scientific Literature
11.	ALA2429326	B	Binding affinity to CDC2L2 (unknown origin)	Homo sapiens	1	ALA2424622	single protein format	Scientific Literature
12.	ALA4025048	B	Inhibition of wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4024706	assay format	Scientific Literature
13.	ALA4043859	B	Inhibition of wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	Homo sapiens	1	ALA4043093	assay format	Scientific Literature
14.	ALA4156938	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4152344	assay format	Scientific Literature
15.	ALA4185717	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	Homo sapiens	2	ALA4184148	assay format	Scientific Literature
16.	ALA4230617	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4229344	assay format	Scientific Literature
17.	ALA4264206	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	Homo sapiens	1	ALA4261600	assay format	Scientific Literature
18.	ALA4307722	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4304811	assay format	Scientific Literature
19.	ALA4333313	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4330132	assay format	Scientific Literature
20.	ALA4357795	B	Binding affinity to wild-type human partial length CDC2L2 (D391 to K730 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	Homo sapiens	1	ALA4354843	assay format	Scientific Literature